This document is an excerpt from the EUR-Lex website
Document C2004/273/22
Case C-348/04: Reference for a preliminary ruling by the Court of Appeal (England & Wales) (Civil Division), by order of that court dated 17 June 2004, in the case of Boehringer Ingelheim KG and others against Swingward Ltd and another
Case C-348/04: Reference for a preliminary ruling by the Court of Appeal (England & Wales) (Civil Division), by order of that court dated 17 June 2004, in the case of Boehringer Ingelheim KG and others against Swingward Ltd and another
Case C-348/04: Reference for a preliminary ruling by the Court of Appeal (England & Wales) (Civil Division), by order of that court dated 17 June 2004, in the case of Boehringer Ingelheim KG and others against Swingward Ltd and another
JO C 273, 6.11.2004, p. 11–12
(ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, SK, SL, FI, SV)
6.11.2004 |
EN |
Official Journal of the European Union |
C 273/11 |
Reference for a preliminary ruling by the Court of Appeal (England & Wales) (Civil Division), by order of that court dated 17 June 2004, in the case of Boehringer Ingelheim KG and others against Swingward Ltd and another
(Case C-348/04)
(2004/C 273/22)
Reference has been made to the Court of Justice of the European Communities by order of the Court of Appeal (England & Wales) (Civil Division), dated 17 June 2004, which was received at the Court Registry on 12 August 2004 for a preliminary ruling in the case of Boehringer Ingelheim KG and others and Swingward Ltd and another on the following questions:
Reboxed products
1. |
Where a parallel importer markets in one Member State a pharmaceutical product imported from another Member State in its original internal packaging but with a new exterior carton printed in the language of the Member State of importation (a ‘reboxed’ product):
|
Overstickered products
2. |
Where a parallel importer markets in one Member State a pharmaceutical product imported from another Member State in its original internal and external packaging to which the parallel importer has applied an additional external label printed in the language of the Member State of importation (an ‘overstickered’ product):
|
Notice
3. |
Where a parallel importer has failed to give notice in respect of a repackaged product as required by the fifth condition of Bristol-Myers Squibb v Paranova, and accordingly has infringed the proprietor's trade mark(s) for that reason only:
|